Results 91 to 100 of about 53,295 (182)

ISOLATION OF NEURAMINIDASE FROM INFLUENZA A VIRUS.

open access: yes, 1960
ISOLATION OF NEURAMINIDASE FROM INFLUENZA A ...
LEWIS WALTER. MAYRON (7958993)
core   +3 more sources

Oseltamivir-Resistant Influenza A(H1N1)pdm09 Viruses, United States, 2013–14

open access: yesEmerging Infectious Diseases, 2015
We report characteristics of oseltamivir-resistant influenza A(H1N1)pdm09 viruses and patients infected with these viruses in the United States.
Margaret Okomo-Adhiambo   +11 more
doaj   +1 more source

Genomic and Clinical Analysis of Influenza A in Hospitalized Adults, 2019–2024: Exploratory Evidence on Neuraminidase and Polymerase Acidic Protein Mutation‐Outcome Associations From a Single Center

open access: yesInfluenza and Other Respiratory Viruses, Volume 20, Issue 11, November 2026.
ABSTRACT Background Antivirals are widely used to treat influenza, but potential resistance mutations remain a major challenge, and clinical data on key resistance mutations are limited. Methods We conducted a retrospective cohort study of 765 adults with RT‐PCR‐confirmed influenza A admitted to Ruijin Hospital, Shanghai, between 2019 and 2024 to ...
Anqi Feng   +5 more
wiley   +1 more source

Influenza treatment and prophylaxis with neuraminidase inhibitors: a review

open access: yes, 2013
Amanda Kamali,1 Mark Holodniy1,21Division of Infectious Diseases, Stanford University School of Medicine, Stanford, CA, USA; 2Office of Public Health, Department of Veterans Affairs, Washington, DC, USAAbstract: Influenza virus is a pathogen that causes ...
Kamali A, Holodniy M
core  

Deciphering the Action of Neuraminidase in Glioblastoma Models

open access: yes, 2023
International audienceGlioblastoma (GBM) contains cancer stem cells (CSC) that are resistant to treatment. GBM CSC expresses glycolipids recognized by the A2B5 antibody.
Carole Colin   +19 more
core   +1 more source

Age‐Specific Effectiveness of Antiviral Agents on the Secondary Household Transmission of Influenza

open access: yesInfluenza and Other Respiratory Viruses, Volume 20, Issue 11, November 2026.
ABSTRACT Objectives We investigate the effects of age, vaccination history, treatment timing, and type of antiviral agent in index cases and household members on the risk of influenza transmission. Methods We conducted a retrospective household survey in Japan between October 2018 and February 2019, enrolling 915 households (3248 members) with ...
Jeonghwa Seo   +3 more
wiley   +1 more source

Matrix Metalloproteinase‐8 Deficiency Alters the Balance Between Viral Clearance and Immunopathology in H1N1 Infection

open access: yesThe FASEB Journal, Volume 40, Issue 19, 15 October 2026.
Mmp‐8 deficiency during H1N1 influenza infection enhances Type I interferon responses, necroptosis‐associated signaling, and adaptive immunity, leading to lower lung viral burden and improved survival, but also amplifies inflammatory lung injury. ABSTRACT Matrix metalloproteinase‐8 (MMP‐8) regulates inflammatory responses, but its contributions to the ...
Xiaoyun Wang   +4 more
wiley   +1 more source

Flocculation of influenza virus by specific anti-neuraminidase antibody [PDF]

open access: yes, 1970
1. Flocculation of purified preparations of influenza virus has been demonstrated to occur in the presence of low dilutions of specific anti-neuraminidase sera. High dilutions of the sera caused microscopic aggregation of virions.
Madeley, C. R., Kendal, Alan P.
core   +1 more source

neuraminidase trees global log file

open access: yes, 2014
Combined log files for neuraminidase trees generated by BEAST for global ...
Trevor Bedford (376961)   +11 more
core   +1 more source

Meeting Report: Risk Assessment of Tamiflu® use under Pandemic Conditions [PDF]

open access: yes, 2008
On 3 October 2007, 40 participants with diverse expertise attended the workshop Tamiflu and the Environment: Implications of Use under Pandemic Conditions to assess the potential human health impact and environmental hazards associated with use of ...
Howard B. M.   +210 more
core   +1 more source

Home - About - Disclaimer - Privacy